Form 8-K/A · Amended current report
Copart 8-K/A, filed Aug 19, 2026
- Filed
- CIK
- 0000900075
- Accession no.
- 0001193125-26-356968
Summary
Copart's Compensation Committee approved compensation arrangements for Jane Pocock in connection with her appointment as President, effective August 1, 2026, including an $804,000 annual base salary, a $643,000 target annual bonus, restricted stock units, and stock options.
Key points
- Jane Pocock became Copart President effective August 1, 2026.
- Copart's Compensation Committee approved her compensation arrangements on August 16, 2026.
- Her package includes an $804,000 annual base salary, a $643,000 target annual bonus, restricted stock units with an $800,000 grant-date value, and an option for 500,000 shares.
- 279,000 of the options are subject to a performance condition requiring Copart's stock to trade at or above 125% of the exercise price.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On August 16, 2026, the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of the Company approved the following compensation arrangements for Jane Pocock in connection with her appointment as President on August 1, 2026. Ms. Pocock will receive a base salary of $804,000 per annum effective as of August 1, 2026; she will also be eligible to receive a target annual bonus of $643,000; …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.